ACAna Collins-Smith

Ana Collins-Smith

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ana Collins-Smith has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Sangeeta Jain

    Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA

    2 shared publications
  • Chasey I. Omere

    Division of Maternal Fetal Medicine, Department of Ob-Gyn, University of Texas Medical Branch, Galveston, TX

    1 shared publication
  • Corey C. Do Clifford

    Dr. Clifford is Assistant Professor and Dr. Behnia is Assistant Professor, Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, and Dr. Pacheco is Professor and Division Chief, Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine and Department of Anesthesiology, Division of Surgical Critical Care, The University of Texas Medical Branch at Galveston, 301 8th St, Galveston, TX 77555,

    1 shared publication
  • Faranak Behnia

    1 shared publication
  • Luis D. Pacheco

    Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas, United States

    1 shared publication
  • Sunil K. Jain

    Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas

    1 shared publication

Latest Publications

  • Cardiomyopathies in Pregnancy

    by Faranak Behnia, Corey C. Clifford, Sangeeta Jain, Chasey I. Omere, Ana Collins-Smith, Luis D. Pacheco

    Cardiomyopathies are uncommon but potentially life-threatening causes of cardiovascular disease in pregnancy. Pregnancy-associated hemodynamic changes may reveal unrecognized cardiomyopathy or exacerbate existing myocardial dysfunction. This review summarizes the diagnosis and management of dilated cardiomyopathy, hypertrophic cardiomyopathy, left ventricular hypertrabeculation/noncompaction cardiomyopathy, Takotsubo cardiomyopathy, and other rare cardiomyopathies during pregnancy. Our discussion will include pregnancy-specific hemodynamic considerations, risk stratification, medical management, labor and delivery planning, postpartum surveillance, and counseling regarding future pregnancy. This review does not address peripartum cardiomyopathy because it is considered separately.

  • Open Access

    L-Citrulline in Maternal–Fetal and Neonatal Health: Metabolic Mechanisms and Emerging Therapeutic Applications

    by Ana Collins-Smith, Sangeeta Jain, Sunil Jain

    L-citrulline is a non-protein amino acid with critical roles in perinatal and neonatal physiology through the intestinal–renal arginine–citrulline axis and nitric oxide (NO) production. During pregnancy, L-citrulline supports placental angiogenesis, vascular adaptation, and fetal growth through augmentation of arginine availability and endothelial NO production. In neonates, particularly preterm infants, developmental immaturity of citrulline and arginine synthesis contributes to hypoargininemia and may increase susceptibility to necrotizing enterocolitis, bronchopulmonary dysplasia with pulmonary hypertension, sepsis, and impaired intestinal function. Although L-citrulline has emerged as a promising modulator of NO bioavailability, prior reviews have largely focused on either adult cardiovascular disease or isolated neonatal applications, with limited integration of its mechanistic and translational relevance across the perinatal and neonatal continuum. Collectively, current evidence supports L-citrulline as a promising translational target in maternal–fetal and neonatal medicine because of its central role in vascular, inflammatory, and metabolic regulation. However, adequately powered clinical trials are needed to define optimal dosing, timing, patient selection, and long-term outcomes before routine clinical implementation can be recommended. This review provides a comprehensive evaluation of L-citrulline metabolism and its therapeutic potential from pregnancy through neonatal life, with emphasis on the intestinal–renal arginine–citrulline axis, endothelial function, and NO-mediated vascular regulation. We specifically examine the role of citrulline in key pathophysiologic mechanisms underlying maternal and neonatal disease, including endothelial dysfunction, impaired NO bioavailability, inflammation, oxidative stress, and abnormal placental vascular remodeling.